A dimorphism shift of hepatitis B virus capsids in response to ionic conditions
Source abstract
Abstract
The dimorphism of HBV capsids (coexistence of T = 3 and T = 4 capsids) was found to be regulatable by controlling the rate of capsid nucleation using cations such as K+ or Ca2+: a quick addition of highly concentrated monovalent and/or multivalent counter-cations resulted in a morphism transition from a thermodynamically more stable, T = 4 capsid-dominant state (>80% of total capsids) to a new state containing ∼1 : 1 amounts of T = 3 and T = 4 capsids. These results suggested that the salts with strong charge screening ability could narrow the difference in nucleation energy barriers between the two states, which were not inter-convertible once formed. The effect of salts was more significant than other factors such as pH or protein concentration in achieving such a dimorphism shift. The general mechanism of HBV capsid dimorphism described here provides a new perspective in understanding the virus assembly during infection and directing the design of non-infectious capsids for nanotechnology applications.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Hepatitis B Virus Studies · Bacteriophages and microbial interactions · Hepatitis C virus research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Polymer Science
University of Akron
Akron
USA
Department of Chemistry
University of Kentucky
Lexington
Funding
National Science Foundation · University of Akron
References (33)
Show source-provided references
1. Šiber · Phys. Rev. E · 2008 · 78 · 5191510.1103/PhysRevE.78.051915 ↗
2. Kim · J. Chem. Phys. · 2014 · 140 · 06B612
3. Harrison · Fields’ Virol. · 2007 · 1 · 59
4. Bruinsma · Phys. Rev. Lett. · 2003 · 90 · 24810110.1103/PhysRevLett.90.248101 ↗
5. Zandi · Biophys. J. · 2006 · 90 · 193910.1529/biophysj.105.072975 ↗
6. Zlotnick · Biochemistry · 1996 · 35 · 741210.1021/bi9604800 ↗
7. Salunke · Biophys. J. · 1989 · 56 · 88710.1016/S0006-3495(89)82735-3 ↗
8. Lavelle · J. Phys. Chem. B · 2009 · 113 · 381310.1021/jp8079765 ↗
9. Krol · Proc. Natl. Acad. Sci. U. S. A. · 1999 · 96 · 1365010.1073/pnas.96.24.13650 ↗
10. Elrad · Nano Lett. · 2008 · 8 · 385010.1021/nl802269a ↗
11. Tang · J. Struct. Biol. · 2006 · 154 · 5910.1016/j.jsb.2005.10.013 ↗
12. Stray · J. Mol. Recognit. · 2006 · 19 · 54210.1002/jmr.801 ↗
13. Katen · Structure · 2013 · 21 · 140610.1016/j.str.2013.06.013 ↗
14. Schlicksup · eLife · 2018 · 7 · e3147310.7554/eLife.31473 ↗
15. Liang · Hepatology · 2009 · 49 · S1310.1002/hep.22881 ↗
16. Birnbaum · J. Virol. · 1990 · 64 · 331910.1128/JVI.64.7.3319-3330.1990 ↗
17. D. L. D. Caspar and A.Klug , in Cold Spring Harbor symposia on quantitative biology , Cold Spring Harbor Laboratory Press , 1962 , vol. 27 , pp. 1–24
18. Crowther · Cell · 1994 · 77 · 94310.1016/0092-8674(94)90142-2 ↗
19. Wingfield · Biochemistry · 1995 · 34 · 491910.1021/bi00015a003 ↗
20. Sun · ACS Omega · 2018 · 3 · 438410.1021/acsomega.8b00021 ↗
21. Zlotnick · Acta Crystallogr., Sect. D: Biol. Crystallogr. · 1999 · 55 · 71710.1107/S090744499801350X ↗
22. Harms · ACS Nano · 2015 · 9 · 908710.1021/acsnano.5b03231 ↗
23. Selzer · Biochemistry · 2014 · 53 · 549610.1021/bi500732b ↗
24. Ceres · Biochemistry · 2002 · 41 · 1152510.1021/bi0261645 ↗
25. Kegel · Biophys. J. · 2004 · 86 · 390510.1529/biophysj.104.040055 ↗
26. Wagner · Biophys. J. · 2015 · 109 · 95610.1016/j.bpj.2015.07.041 ↗
27. Moerman · J. Phys. Chem. B · 2016 · 120 · 600310.1021/acs.jpcb.6b01953 ↗
28. Zlotnick · Biochemistry · 1999 · 38 · 1464410.1021/bi991611a ↗
29. Stray · Biochemistry · 2004 · 43 · 998910.1021/bi049571k ↗
30. Choi · Virology · 2005 · 332 · 45410.1016/j.virol.2004.11.019 ↗
31. Katen · Methods Enzymol. · 2009 · 455 · 39510.1016/S0076-6879(08)04214-6 ↗
32. Wynne · Mol. Cell · 1999 · 3 · 77110.1016/S1097-2765(01)80009-5 ↗
33. Uetrecht · Phys. Chem. Chem. Phys. · 2010 · 12 · 1336810.1039/c0cp00692k ↗